Sunovion Respiratory Development Inc is categorized under in San Diego, CA and active since 2012.
Sunovion Respiratory Development Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact William Gerhart at the company’s single location by writing to 11455 El Camino Real, San Diego, California CA 92130 or by phoning (858) 436-1616. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sunovion Respiratory Development Inc |
| Contact Person: | William Gerhart |
| Address: | 11455 El Camino Real, San Diego, California 92130 |
| Phone Number: | (858) 436-1616 |
| Website Address: | elevationpharma.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 325412 |
| Share This Business: |
Sunovion Respiratory Development Inc was started in 2012 to provide professional under the SIC code 2834 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact William Gerhart for inquiries that concern Sunovion Respiratory Development Inc by calling the company number (858) 436-1616, as your correspondence is most welcome. Additionally, the physical location of the single location of Sunovion Respiratory Development Inc can be found at the coordinates 32.924898,-117.235291 as well as the street address 11455 El Camino Real in San Diego, California 92130.
For its online presence, you may visit Sunovion Respiratory Development Inc’s website at elevationpharma.com and engage with its social media outlets through on Twitter and on Facebook.